IHME CLIENT SERVICES

8 billion people. 1 data suite.

The Institute for Health Metrics and Evaluation (IHME) is a global center of excellence in health data and analytics.

IHME Client Services is a social enterprise that supports IHME's mission to deliver to the world timely, relevant, and scientifically valid evidence to improve health policy and practice. IHME Client Services provides data and analytic guidance to heads of state, governments and health ministries, major philanthropists, fortune 500 companies in the pharmaceutical, insurance and health care and many other industries.

IHME resources at-a-glance:

500+ full-time professionals
30+ full-time university faculty
30-member scientific council
19,000+ international collaborators

IHME can provide comprehensive, comparable estimates to help facilitate:

Investments in health and impact measurement
Cross-functional knowledge sharing
Clinical trial site selection and design
Disease and modifiable risk factor forecasting
Quantifying disease prevalence and burden across market

IHME, housed at the University of Washington and founded in 2007, is an independent population health research organization that works with collaborators around the world to develop evidence that informs health policy and practice.

The GBD study measures health outcomes in a comprehensive, comparable way for all countries.

IHME data are compiled to cover 204 countries/territories including 900+ subnational units.

For more information about commercial use of IHME’s data and tools, please contact us below.

We deliver customized, evidence-based support for organizations' data-driven decisions.

Innovate Vaccine and Treatment
Support Research & Development (R&D) prioritization, pipeline valuation, and evidence generation for novel antimicrobials and stewardship initiatives.

Identify Future Market Size
Anticipate disease burden shifts, forecast therapeutic area growth, and assess the long-term impact of prevention or intervention strategies.

Support Clinical Representativeness
Enable equity-driven clinical trial planning, real-world evidence generation, and targeted health equity strategies for diverse U.S. populations.

Address Drivers of Disease
Optimize clinical trial site selection, support corporate social responsibility & access programs, and integrate nonclinical drivers into disease & outcomes modeling.

Assess Economic Impact of Health Spending
Inform Health Economics & Outcomes Research (HEOR) studies, pricing and reimbursement strategies, and budget impact analyses for new therapies.

Go Local with Precision Maps
Up to date, granular data to help address and mitigate risk due to factors that impact local communities’ health and wellbeing.